Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Partial Conversion of Convertible Note

16th Mar 2022 09:52

RNS Number : 9645E
Empyrean Energy PLC
16 March 2022
 

Empyrean Energy Plc / Index: AIM / Epic: EME / Sector: Oil & Gas

 

Empyrean Energy plc

 

Partial Conversion of Convertible Note

 

16 March 2022

 

Empyrean Energy ("Empyrean" or the "Company"), the oil and gas development company with interests in China, Indonesia and the United States, advises that it has received a conversion notice to convert 8,750,000 Ordinary Shares ("Shares") at a conversion price 8p per Share under the existing Convertible Loan Note Agreement as announced on 16 December 2021 ('Partial Conversion"). The Partial Conversion reduces the amount owing on the Convertible Note by £700,000.

 

Application will be made for the admission of the Shares to trading on AIM ("Admission"). Admission is expected to take place on 22 March 2022. The Shares will rank pari passu with the existing ordinary shares on issue.

 

Following Admission, the Company's enlarged issued share capital will comprise 646,070,780 ordinary shares of 0.2p each (the "Shares"), each with voting rights. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, securities of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

 

-ENDS-

 

 

For further information please contact the following:

 

Empyrean Energy plc

Tom Kelly

Tel: +61 6146 5325

Cenkos Securities plc (Nominated Advisor and Broker)

Neil McDonald

Tel: +44 (0) 131 220 9771

Pete Lynch

Tel: +44 (0) 131 220 9772

 

First Equity Limited (Joint Broker)

Jason Robertson

Tel: +44 (0) 20 7330 1883

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKZGMFLVMGZZG

Related Shares:

Empyrean
FTSE 100 Latest
Value8,843.70
Change33.96